Literature DB >> 14664916

Somatotropic-axis deficiency affects brain substrates of selective attention in childhood-onset growth hormone deficient patients.

M Lijffijt1, P S Van Dam, J L Kenemans, H P F Koppeschaar, W R de Vries, M L Drent, A Wittenberg, C Kemner.   

Abstract

Reduced levels of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) are associated with deteriorated cognitive performance in senescence. Little work has been done on the effect of GH and IGF-1 on a crucial aspect of cognition, selective attention. This study investigated the effect of GH/IGF-1 on performance and brain potentials (EEG) during a selective-attention task in patients with low levels of GH and IGF-1 (childhood-onset growth hormone deficiency) compared to healthy controls. Detection of occasional visual target patterns was impaired in patients. This was paralleled by a reduction in an attention-related brain potential, which has been associated previously with anterior cingulate cortex functioning.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14664916     DOI: 10.1016/j.neulet.2003.09.028

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence.

Authors:  Han Yan; Matthew Mitschelen; Georgina V Bixler; Robert M Brucklacher; Julie A Farley; Song Han; Willard M Freeman; William E Sonntag
Journal:  J Endocrinol       Date:  2011-07-12       Impact factor: 4.286

2.  Effect of growth hormone replacement therapy on cognition after traumatic brain injury.

Authors:  Walter M High; Maria Briones-Galang; Jessica A Clark; Charles Gilkison; Kurt A Mossberg; Dennis J Zgaljardic; Brent E Masel; Randall J Urban
Journal:  J Neurotrauma       Date:  2010-09       Impact factor: 5.269

3.  Prenatal exposure to endocrine disrupting chemicals is associated with altered DNA methylation in cord blood.

Authors:  Katharina Mattonet; Nikola Nowack-Weyers; Vanessa Vogel; Dirk Moser; Sascha Tierling; Monika Kasper-Sonnenberg; Michael Wilhelm; Michael Scherer; Jörn Walter; Jan G Hengstler; Axel Schölmerich; Robert Kumsta
Journal:  Epigenetics       Date:  2021-09-16       Impact factor: 4.861

Review 4.  Growth factors as mediators of exercise actions on the brain.

Authors:  M Llorens-Martín; I Torres-Alemán; José L Trejo
Journal:  Neuromolecular Med       Date:  2008-02-20       Impact factor: 3.843

5.  Astrocytic IGF-IRs Induce Adenosine-Mediated Inhibitory Downregulation and Improve Sensory Discrimination.

Authors:  José Antonio Noriega-Prieto; Laura Eva Maglio; Jonathan A Zegarra-Valdivia; Jaime Pignatelli; Ana M Fernandez; Laura Martinez-Rachadell; Jansen Fernandes; Ángel Núñez; Alfonso Araque; Ignacio Torres-Alemán; David Fernández de Sevilla
Journal:  J Neurosci       Date:  2021-04-28       Impact factor: 6.167

6.  Insulin-like growth factor-1 in CNS and cerebrovascular aging.

Authors:  William E Sonntag; Ferenc Deak; Nicole Ashpole; Peter Toth; Anna Csiszar; Willard Freeman; Zoltan Ungvari
Journal:  Front Aging Neurosci       Date:  2013-07-02       Impact factor: 5.750

7.  Preliminary investigation of plasma levels of sex hormones and human growth factor(s), and P300 latency as correlates to cognitive decline as a function of gender.

Authors:  Eric R Braverman; Thomas J H Chen; Amanda L C Chen; Mallory M Kerner; Howard Tung; Roger L Waite; John Schoolfield; Kenneth Blum
Journal:  BMC Res Notes       Date:  2009-07-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.